Literature DB >> 23846150

Comparison of the 99th percentiles of three troponin I assays in a large reference population.

Astrid Petersmann, Till Ittermann, Cornelia Fries, Norbert Lubenow, Thomas Kohlmann, Anders Kallner, Andreas Greinacher, Matthias Nauck.   

Abstract

BACKGROUND: The IFCC Task Force on Clinical Applications of Cardiac Biomarkers suggests comparing several contemporary sensitive troponin assays in the same, sufficiently large reference population.
METHODS: Three contemporary sensitive assays were used to measure troponin I concentration in samples from a uniquely large healthy population (2404 individuals) and in a sub-group with tighter inclusion criteria of 908 individuals. The 99th percentiles were calculated using quantile regression which takes the entire population into account.
RESULTS: The 99th percentile for the ARCHITECT STAT Troponin I assay was 21 ng/L, 31 ng/L for the ADVIA Centaur Troponin I-Ultra assay and 28 ng/L for the Dimension Vista cTnI assay. Significantly higher values were found in males than in women only in the Dimension Vista cTnI assay and in the subgroup for the ARCHITECT STAT Troponin I assay.
CONCLUSIONS: Quantile regression provides a tool to accurately estimate the 99th percentile and establish a continuous function of the relation between the 99th percentile and the age and gender. There was no age dependency demonstrated. A gender difference was found in one assay but inconclusive in another and not demonstrated in a third.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23846150     DOI: 10.1515/cclm-2013-0113

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  1 in total

1.  Effect of Outlier Elimination on the 99th Percentile Upper Reference Limits of High-Sensitivity Cardiac Troponin I Assays Based on a Strictly Selected Healthy Reference Population.

Authors:  Sunyoung Ahn; Hyun-Ki Kim; Woochang Lee; Sail Chun; Won-Ki Min
Journal:  Ann Lab Med       Date:  2022-05-01       Impact factor: 3.464

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.